More about

Visual Acuity

News
March 04, 2023
1 min watch
Save

VIDEO: CSF-1 improved, sustained near visual acuity

VIDEO: CSF-1 improved, sustained near visual acuity

ATLANTA — A study of CSF-1 showed an improvement in near visual acuity as well as distance, according to a study presented at SECO 100.

News
February 21, 2023
1 min read
Save

FDA accepts new drug application for presbyopia treatment

FDA accepts new drug application for presbyopia treatment

The FDA has accepted a new drug application for CSF-1 for the treatment of presbyopia, according to a press release from Orasis Pharmaceuticals.

News
February 09, 2023
1 min read
Save

Four-year results show no vision gains with preventive aflibercept in NPDR

Four-year results show no vision gains with preventive aflibercept in NPDR

Four-year outcomes of the DRCR Retina Network Protocol W study showed that preventive aflibercept vs. sham treatment in eyes with moderate to severe NPDR leads to anatomic improvement but no gain in visual acuity.

News
February 07, 2023
1 min read
Save

High prevalence of visual impairment found among older adults

High prevalence of visual impairment found among older adults

A study found that more than one in four U.S. adults aged 71 years and older are visually impaired, with increasing prevalence related to older age, less education, lower income, non-white race and Hispanic ethnicity.

News
December 20, 2022
1 min read
Save

Phentolamine improved distance-corrected near visual acuity

Phentolamine improved distance-corrected near visual acuity

SAN DIEGO — Phentolamine with and without low-dose pilocarpine significantly improved distance-corrected near visual acuity without compromising distance vision, according to a poster presented at Academy 2022.

News
November 29, 2022
3 min watch
Save

VIDEO: Visual acuity in wet AMD maintained or improved after switch to brolucizumab

VIDEO: Visual acuity in wet AMD maintained or improved after switch to brolucizumab

In this Healio Video Perspective, Mathew W. MacCumber, MD, PhD, discusses his poster presentation on brolucizumab treatment from the Retina Society meeting.

News
November 07, 2022
1 min read
Save

Ophthalmologists debate Oxervate vs. neurotization for neurotrophic keratopathy

Ophthalmologists debate Oxervate vs. neurotization for neurotrophic keratopathy

MONTEREY, Calif. — There is more than one way to treat neurotrophic keratopathy.

News
November 03, 2022
1 min read
Save

Diabetic macular edema treatment promising at 24 weeks in phase 2 study

Diabetic macular edema treatment promising at 24 weeks in phase 2 study

UBX1325 met safety and efficacy endpoints at 24 weeks in the phase 2 BEHOLD study in patients with diabetic macular edema, according to a press release from Unity Biotechnology.

News
October 28, 2022
1 min watch
Save

VIDEO: NovaSight CEO discusses CureSight vs. patching for amblyopia treatment

VIDEO: NovaSight CEO discusses CureSight vs. patching for amblyopia treatment

CHICAGO — In this Healio Video Perspective from Eyecelerator@AAO, Ran Yam, of NovaSight, discusses positive topline study data for the CureSight amblyopia therapy device.

News
October 28, 2022
2 min read
Save

Disparities in race, ethnicity, socioeconomics affect visual impairment in adolescents

Disparities in race, ethnicity, socioeconomics affect visual impairment in adolescents

Adolescents who identified as Black or Mexican American and those from low-income families were more likely to report poor visual function and to present with worse visual acuity, according to a study.

View more